Women are at high risk of dying from unrecognized cardiovascular disease. Many differences in cardiovascular disease between men and women appear to be mediated by vascular smooth muscle cells (SMC). Because estrogen reduces the proliferation of SMC, we hypothesized that activation of estrogen receptor-␣ (ER␣) by agonists or by growth factors altered SMC function. To determine the effect of growth factors, estrogen, and ER␣ expression on SMC differentiation, human aortic SMC were cultured in serum-free conditions for 10 days. SMC from men had lower spontaneous expression of ER␣ and higher levels of the differentiation markers calponin and smooth muscle ␣-actin than SMC from women. When SMC containing low expression of ER␣ were transduced with a lentivirus containing ER␣, activation of the receptor by ligands or growth factors reduced differentiation markers. Conversely, inhibiting ER␣ expression by small interfering RNA (siRNA) in cells expressing high levels of ER␣ enhanced the expression of differentiation markers. ER␣ expression and activation reduced the phosphorylation of Smad2, a signaling molecule important in differentiation of SMC and initiated cell death through cleavage of caspase-3. We conclude that ER␣ activation switched SMC to a dedifferentiated phenotype and may contribute to plaque instability. (Circ Res. 2006;99:477-484.)
S ince 1984, more women than men have died from cardiovascular diseases, although the prevalence of diagnosed disease is lower among women. 1 Women have higher rates of stable angina, high blood pressure, congestive heart failure, and stroke but have less angiographic evidence of atherosclerotic plaques and have fewer myocardial infarctions than men. 1 The inhibition of collagen production, smooth muscle proliferation, and endothelial dysfunction by estrogen may delay the formation of plaques in women until after menopause. 2 Hormone replacement therapy started more than 10 years after menopause increases a woman's risk for myocardial infarction, 3, 4 although therapy initiated near menopause may be more effective in preventing coronary heart disease. 5 Additionally, because of gender differences in symptoms during acute coronary events and in response to interventional strategies, it is difficult to correctly diagnose and treat women. 6, 7 A few studies comparing vascular wall properties and disease presentation of men and women with symptoms of coronary artery disease provide insight into the complicated effects of female hormones and their receptors in vascular cells. Although women with acute coronary syndromes are often free of angiographically visible stenoses, testing of coronary flow reserve demonstrates endothelial and smooth muscle dysfunction. 8, 9 Younger women who die from coronary artery thrombosis are more likely than men or postmenopausal women to have plaque erosion, rather than rupture of a lipid-rich plaque. 10, 11 Plaque erosions are characterized by loss of endothelial cells covering a nonocclusive, smooth muscle cell (SMC)-and hyaluronan-rich plaque with few inflammatory cells or type I collagen. 12 It is speculated that migration of dedifferentiated SMC and expression of hyaluronan weakens endothelial cell adhesion and predisposes the coronary arteries for thrombotic events. 12 After menopause, women experience a dramatic rise in aortic stiffness, which may cause hypertension. 13 In those who develop coronary artery disease, the plaques become more numerous with larger lipid cores and thinner fibrous caps marked by calcification. 11 It is uncertain how matrix deposition and plaque stability are affected by the lack of estrogen or by growth factors that activate the estrogen receptor (ER). 2 Because SMC are responsible for many of the differences in coronary disease noted between men and women, such as microvessel dysfunction, plaque erosion, and matrix deposition, we sought to understand the role of ER␣ in smooth muscle differentiation in estrogen-or growth factor-rich environments to mimic gender or menopausal effects. In this study, we obtained aortic SMC from male and female donors and determined the effects of ER␣ expression, estrogen, and growth factors on differentiation, survival, and adherence of these cells.
Materials and Methods

Explantation and SM ␣-Actin Detection
Following informed consent, sections of aorta were obtained from heart transplant donors and recipients at The Ohio State University Medical Center, as approved by the institutional review board. Aortic slices were stripped of endothelium and adventitia, rinsed, and cut into small bits. The average age (ϮSEM) for females and males examined in this study was 32.6Ϯ6.39 and 47.4Ϯ8.62, respectively (nϭ5 each). No statistical difference in age was observed between the donors and recipients or between genders. The SMC were expanded in growth media with amphotericin and gentamicin (Clonetics/Cambrex, Walkersville, Md, and Cascade Biologics, Portland, Ore), then tested for smooth muscle (SM) ␣-actin expression using FACS Calibur flow cytometer (BD Biosciences, San Jose, Calif). Cell populations containing at least 85% positive staining for SM ␣-actin were used for subsequent studies.
Real-Time PCR for ER␣
ER␣ mRNA was analyzed by real-time PCR in SMC from 5 male donors and 5 female donors that were starved for 5 days to allow ER␣ upregulation. TaqMan primers and probe designed by Primer 3 software (http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi 14 ) were synthesized by Applied Biosystems (Foster City, Calif). The following primers were used to detect ER␣: forward, 5Јagctcctcctcatcctctcc-3Ј; reverse, 5Ј-tctccagcagcaggtcatag-3Ј; and probe 5Ј-6FAM-tcaggcacatgagtaacaaaggca-TAMRA-3Ј. RNA was isolated using NucleoSpin RNA II (BD Clontech, Mountain View, Calif), and cDNA generated using random hexamers (Invitrogen, Carlsbad, Calif). A 111-bp product from ER␣ was amplified over 40 cycles with 18S RNA as internal control using the ABI PRISM 7700 Sequence Detection System (Applied Biosystems).
Cloning of ER␣ into EGFP-pLenti6/V5 Plasmid and Transduction
The pLenti6/V5-D-TOPO vector (Invitrogen) was engineered to contain an enhanced green fluorescent protein (EGFP) surrounded by additional restriction sites and designated pLenti-EGFP (generously provided by Mark Wewers, Ohio State University). cDNA for ER␣ was amplified by PCR from a pBK-CMV/ER␣ plasmid kindly provided by Robert Brueggemeier (Ohio State University), introducing EcoRI and EcoRV restriction sites. EGFP was removed from pLenti-EGFP by digestion with EcoRI and EcoRV and replaced with ER␣ to generate pLenti-ER␣. pLenti vector lacking EGFP was used as a control. Purified pLenti-ER␣ or empty vector control (3 g) were transfected with 2 g of pMD.G and 10 g of pCMV⌬R8.2 helper plasmids (kindly provided by Dr K. Boris-Lawrie, Ohio State University) into HEK293FT cells according to the directions for the ViraPower Lentiviral Expression System. Virus secreted into the media was concentrated (Vivaspin 100 000 MWCO; Vivascience, Germany) and titered in SMC cultures, with blasticidin (2 g/mL) for selection. SMC were then transduced with the virus for each experiment at approximately 5 multiplicity of infection and incubated overnight in growth media containing 6 g/mL polybrene.
Transfection of Small Interfering RNA Plasmids
SMC (1ϫ10 6 ) were transfected with 10 g of control or ER␣ small interfering RNA (siRNA) plasmid (Panomics, Redwood City, Calif) using nucleofection (Amaxa, Gaithersburg, Md). Transfection efficiency was monitored using 2 g of pmaxGFP plasmid (Amaxa).
SMC Differentiation and Activation
Differentiation experiments were performed on SMC in the following groups, seeded in an 8-well plate as noted: native cells expressing endogenous ER␣ (7ϫ10 4 cells per well), cells with low expression of ER␣ to be transduced with ER␣ lentivirus (8ϫ10 4 ), and cells with high ER␣ levels transfected with ER␣ siRNA (1.8ϫ10 5 ). After recovery, the cells were starved overnight in phenol red and serum-free basal media (EBM-PRF) (Clonetics/Cambrex) and exposed for 10 days to vehicle control (either 4 mol/L HCL or 1:400 000 dilution ethanol), 17␤-estradiol (10 nmol/L; Sigma, St Louis, Mo), the ER␣ agonist propyl pyrazole triol (PPT) (10 nmol/L; Tocris Cookson, Ellisville, Mo), epidermal growth factor (EGF) (10 ng/mL, R&D Systems, Minneapolis, Minn), platelet-derived growth factor-BB (PDGF-BB) (10 ng/mL; R&D Systems), or transforming growth factor-␤1 (TGF␤1) (5 ng/mL; R&D Systems) in EBM-PRF. Agonists or vehicle controls were added each day and then cells were lysed in cell lysis buffer (Cell Signaling Technology, Danvers, Mass). Samples of the culture media at the end of the experiment were quantitated for active TGF␤1 by ELISA (Quantikine, R&D Systems). Activation studies were performed on SMC stably transduced with pLenti control or ER␣ (7ϫ10 4 cells per well or 2ϫ10 5 cells per 25-cm 2 flask), incubated for the times indicated using agonists as listed above, then lysed with cell lysis buffer or CelLytic NuCLEAR Extraction Kit (Sigma). Equal protein amounts (20 to 50 g) were subjected to Western blot analysis and detected with SuperSignal West Femto Maximum Sensitivity Substrate (Pierce, Rockford, Ill) and the Fluor S-Max system (Bio-Rad, Hercules, Calif). Smooth muscle (SM) ␣-actin, ␤-actin, and calponin antibodies were obtained from Sigma. Antibodies to phospho-ER␣ and cleaved caspase-3 were from Cell Signaling Technology. Cyclin D1 (clone DCS-6), Erk2 and ER␣ (HC20) antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, Calif).
ER␣ Transcriptional Activation
Stably transduced SMC were transfected with an estrogen response element (ERE) reporter construct producing secreted alkaline phosphatase (SEAP) (Clontech/BD Biosciences) using Effectene (Qiagen, Valencia, Calif). The SEAP signal was obtained over 3 days and normalized as a percentage of the maximum signal achieved.
Immunofluorescence for ER␣
Virally transduced SMC were fixed in 70% ETOH, permeabilized and blocked with 0.05% triton/1% goat serum. Cells were incubated overnight with ER␣ antibody (Ab-16, Lab Vision-Neomarkers, Fremont, Calif) in 1% goat serum. ER␣ was detected with Alexa Fluor 568 anti-rabbit secondary antibody (Molecular Probes, Invitrogen) and a DP-11 digital camera connected to an IX-50 inverted microscope with 10ϫ objective (Olympus, Melville, NY).
Cell Density
Phase contrast images were taken using identical settings at day 10 of the differentiation experiments using the DP-11 digital camera and IX-50 inverted microscope with 4ϫ objective (Olympus). Quantity One colony counting software (Bio-Rad) was used to detect live cells (gray) but exclude apoptotic cells (white). Numbers were normalized to vehicle control samples for each cell population or control transfection/transduction cells.
Statistics
Real-time PCR results for ER␣ expression were analyzed using longitudinal regression over 10 experiments to test the difference in ⌬ cycle times, which are normally distributed. Western blot densitometry ratios for contractile proteins in starved or PDGF-stimulated SMC from 6 people were compared using a mixed model regression to account for correlation within cell lines. Densitometry values from the remaining immunoblots were normalized to loading controls and by the vehicle control sample for the control group, compared by 2-factor ANOVA (Stata version 9; StataCorp, College Station, Tex), and pairwise comparisons were adjusted using the Holm's method. 15
Results
Low-Level Expression of ER␣ in Human Aortic Smooth Muscle
Estrogen receptors are present in healthy aortic SMC and regulate growth. 2 Because genes that affect cell growth often change cell differentiation, and ER␣ enhances proliferation in transformed cells, we hypothesized that the expression and activation of SMC ER␣ modulated cell differentiation. The ER␣ mRNA level, stated as a fold induction above the SMC population containing the lowest level of ER␣, was Ϸ4.3 times higher on average for female donors than for male donors (PϽ0.001, Figure 1A ). By comparison, serving as a positive control, the ER␣ level for the breast cancer line MCF7 was Ϸ1000 times higher than SMC containing the lowest ER␣ levels, whereas as a negative control, the colon cancer cell line HT29 had little to no ER␣ detected by PCR. For subsequent studies, we used SMC from either the female donor with the greatest amount of ER␣ or the male donor with the lowest ER␣ expression. We confirmed proportional ER␣ protein expression in these 2 cell populations ( Figure 1B ).
SMC Containing ER␣ Failed to Differentiate
Because growth factors activate ER␣ and TGF␤1 causes differentiation of SMC, 16, 17 SMC expressing the highest ER␣ levels and the lowest ER␣ levels were treated with these growth factors as well as ER␣ ligands (PPT and 17␤estradiol). As shown, cells with high ER␣ levels had little expression of the differentiation markers SM ␣-actin or calponin except in the presence of TGF␤1 (Figure 2A ). In contrast, cells with lower levels of ER␣ retained both SM ␣-actin and calponin in all conditions except when incubated with EGF or PDGF (Figure 2A ). We observed that low ER␣ cells had significantly greater amounts of calponin (PϽ0.0001 overall) and greater amounts of SM ␣-actin (Pϭ0.0001 overall) compared with high ER␣-expressing cells ( Figure 2B ). Individual comparisons are as shown in Figure 2B .
Because SMC from the low ER␣ (male) donor had more differentiation markers than the high ER␣ (female) donor, we further characterized basal differentiation of SMC from other male or female donors (nϭ3 each). As shown in Figure 2C , vehicle control-stimulated SMC from male donors had high levels of calponin but lost much of this marker on PDGF stimulation, similar to cells in Figure 2A . In contrast, female donor SMC expressed only low levels of calponin in either condition. Consequently, the average calponin ratio was significantly higher for SMC from men than for SMC from women (Pϭ0.0281).
Transduction of ER␣ Inhibited SMC Differentiation
Because ER␣ expression correlated with SMC dedifferentiation, we examined whether induced expression of ER␣ in low ER␣-containing cells directly inhibited SMC differentiation. Transduction efficiency was determined by ER␣ immunofluorescent staining ( Figure 3A ).Transduction of ER␣ lowered calponin (PϽ0.0001) and SM ␣-actin (PϽ0.0001) expression overall. ER␣-expression reduced SM ␣-actin in response to 17␤-estradiol, PPT, and TGF␤1 treatment and reduced calponin in response to vehicle, 17␤-estradiol, or PPT ( Figure  3B and 3C, probability values as shown). In contrast to these cell markers, cyclin D increased on transduction of ER␣ (Pϭ0.0001 overall).
Interruption of ER␣ by siRNA Augmented TGF␤1-Induced Differentiation
Because high native levels of ER␣ correlated with low levels of SMC differentiation markers, we next reduced ER␣ expression through siRNA to enhance their differentiation program. High transfection efficiency was obtained using pmaxGFP plasmid DNA in cotransfections ( Figure 4A) . A reduction in ER␣ protein was confirmed in the siRNAtransfected cells compared with the empty vector control ( Figure 4A ).
We found that reduced ER␣ expression led to higher levels of differentiation markers. ER␣ siRNA upregulated calponin expression overall (Pϭ0.0038), with significant pairwise difference occurring in TGF␤1-treated cells ( Figure 4B and C). Although ER␣ siRNA slightly raised SM ␣-actin levels in cells incubated with TGF␤1, the increase was not significant (Pϭ0.1542).
Ligand Activation of ER␣ Inhibited Smad2 Phosphorylation
We next investigated ligand-dependent ER␣ activation by 17␤-estradiol and PPT, and the ligand-independent activation by EGF and PDGF. A low level of ER␣ phosphorylation was observed in the ER␣-transduced cells in the vehicle-treated condition, whereas 17␤-estradiol and PPT preferentially phosphorylated ER␣ S118 , and EGF and PDGF phosphorylated ER␣ S167 (Figure 5A ). TGF␤1 caused no activation above vehicle control of either serine residue.
In contrast to the activation by phosphorylation seen with EGF and PDGF, only 17␤-estradiol and PPT activated transcription of an ERE reporter construct ( Figure 5B , Pϭ0.0013 for 17␤-estradiol and Pϭ0.0008 for PPT compared with vehicle). Activation for up to ten days with EGF, Figure 3 . SMC dedifferentiate following transduction of ER␣. SMC transduced with either an empty vector (pLenti) or ER␣ cDNA were exposed for 10 days in EBM-PRF with various stimuli as indicated in Materials and Methods and Figure 2 PDGF-BB or TGF␤1 caused no detectable signal above vehicle control samples (data not shown). As a partial explanation for the transcriptional inactivity of ER␣ phosphorylated by growth factors, we found that stimulating the cells with 17␤-estradiol, but not EGF, PDGF-BB or TGF␤1, for 20 to 60 minutes caused nuclear translocation of ER␣ ( Figure 5B and data not shown).
Because our differentiation analysis suggested that TGF␤1 elevated SMC differentiation markers in the presence of ER␣ but full expression of these markers required lower levels of ER␣, we examined whether ER␣ inhibited TGF␤ signaling by interfering with Smad activation, as previously described. 18 Because 17␤-estradiol or PPT potently reduced SMC differentiation, we determined whether 17␤-estradiol inhibited TGF␤1 signaling through Smads. TGF␤1 induced the phosphorylation of Smad2 in pLenti or ER␣-transduced SMC for up to 60 minutes ( Figure 5C ). However, Smad2 phosphorylation was reduced if the ER␣-transduced cells were preincubated with 17␤-estradiol 30 minutes before activation. The relevance of TGF␤1 to the differentiation of SMC was examined by measuring whether the cells spontaneously produced TGF␤1 and whether this production correlated to cellular differentiation. Active TGF␤1 was detected in the supernatant of pLenti-transduced SMC at 49.0Ϯ27.9 pg/mL in the vehicle control condition and 67.2Ϯ45.4 and 110.7Ϯ42.1 after 17␤-estradiol or PPT incubation, respectively (no significant differences, nϭ2, meanϮSEM). Transduction of ER␣ in the cells did not alter TGF␤1 production suggesting ER␣ expression altered the response to TGF␤1 (45.6Ϯ23.1, 49.8Ϯ33.6 and 112.0Ϯ39.7 for vehicle, 17␤estradiol, and PPT exposed cells, respectively, nϭ2).
Ligand Activation of ER␣ Initiated Apoptosis
Because estrogen inhibits the growth of SMC and causes apoptosis, 2, 19 we examined the initiation of apoptosis in the presence of ER␣ agonists. Indeed, SMC transduced to express ER␣ had evidence of caspase-3 activity when stimulated with 17␤-estradiol or PPT ( Figure 6A, Pϭ0.0231 and Pϭ0.0646, respectively; nϭ2).
The effects of ER␣ expression on cell growth were apparent by cell detachment when ER␣-transduced SMC were treated with 17␤-estradiol ( Figure 6B , lower right) or PPT (not shown), indicating that cells were undergoing apoptosis. Consequently, fewer ER␣-transduced cells were counted after 17␤-estradiol or PPT treatment compared with pLenti-transduced cells (Pϭ0.0006 overall; Figure 6D , i). Consistent with this observation, cells natively expressing high levels of ER␣ had significantly lower cell densities than the low-ER␣ cells when treated with 17␤-estradiol or PPT (Pϭ0.0003 overall; Figure 6D , ii). Finally, a small increase in cell density was found overall (Pϭ0.0274) when the high-ER␣ SMC were transfected with ER␣ siRNA, although no individual paired comparisons were significant ( Figure 6C and 6D, iii).
Discussion
The present study extends the role of ER␣ in vascular SMC beyond its ability to inhibit growth. To understand differences in SMC status between men and women, we characterized aortic SMC differentiation and ER␣ expression in these 2 groups. We detected significantly higher levels of ER␣ in SMC from our female donors compared with SMC from male donors. The inverse was true for differentiation markers, however, as cells from men expressed greater levels of SM ␣-actin and calponin protein under starved conditions, pro- viding a connection between ER␣ expression and differentiation.
We analyzed the effect of 2 ER␣ ligands and 3 growth factors on cell populations containing the lowest and highest levels of ER␣. SMC differentiation markers remained high for cells natively expressing low amounts of ER␣ whether incubated with vehicle, ER␣ agonists, or TGF␤1. However, EGF and PDGF decreased SM ␣-actin and calponin levels in these cells, similar to published accounts. 20 In contrast, cells expressing high native ER␣ had a low level of SM ␣-actin and calponin under most conditions except when treated with TGF␤1. Similar findings were observed in cells virally transduced with ER␣, which resulted in their dedifferentiation. Only TGF␤1 could partially overcome the inhibitory effect of ER␣. These data indicated that ER␣ may play a role in causing the low contractile protein levels detected in SMC from women. The ability of ER␣ to inhibit differentiation was unexpected, because ER␣ is known to inhibit growth and would be expected to induce differentiation. In contrast, ER␣ caused an increase in cyclin D1 expression, indicating that growth inhibition did not align with quiescence. To confirm this biological role for ER␣, we found that reduction in ER␣ resulted in greater contractile protein expression, especially in the presence of TGF␤1.
Several possible pathways could be involved in the reduced SMC differentiation caused by ER␣. Inhibition of cell cycle regulators and activation of proliferation genes such as cyclin D are known to occur in ER␣-positive breast cancer cells exposed to 17␤-estradiol. 21 Similar changes in SMC could induce a phenotypic switch from differentiated to proliferating or migratory SMC. Alternatively, ER␣ may inhibit transcription by shunting coactivator proteins such as p300/CBP away from other transcription factors, some of which are necessary for smooth muscle gene expression. [22] [23] [24] ER␣ activates transcription at estrogen response elements on DNA, but is known to suppress the TGF␤1/Smad pathway by binding to and repressing Smad2 and -3, positive regulators of contractile protein transcription in SMC. 18, 25 In agreement, Smad2 phosphorylation was inhibited by estrogen in ER␣transduced SMC in the current study. Because the SMC released detectable levels of active TGF␤1, the ability of ER␣ to inhibit Smad-regulated differentiation is a likely mechanism of action.
Cytoplasmic signaling pathways activated by ER␣ including phosphatidylinositol 3-kinase and Akt, growth factor receptor autophosphorylation, mitogen-activated protein kinases (MAPKs), and src kinases can contribute to SMC dedifferentiation. 19,26 -28 A positive-feedback loop also exists in which S118 of ER␣ is phosphorylated by 17␤-estradiol and MAPK, whereas S167 of ER␣ is phosphorylated through the Akt pathway. 16, 29, 30 Depending on the stimulus, we saw preferential phosphorylation of ER␣ epitopes in SMC, indi- Figure 5 . Ligand activation of ER␣ causes nuclear translocation and inhibition of Smad2 phosphorylation. SMC transduced with pLenti or ER␣ virus were stably selected with blasticidin and activated with the various stimuli as indicated previously. A, Western blots from cells activated for 20 minutes were sequentially immunoblotted with antibodies to phospho-ER␣ (S167), phospho-ER␣ (S118), ER␣, and Erk2, with stripping of the membrane between antibodies. Shown is a representative image from 2 experiments. B, Stably transduced cells were transfected with an estrogen response element reporter construct producing secreted alkaline phosphatase (SEAP) and were treated as described for up to 3 days. Aliquots of the media were analyzed for SEAP each day, and luminescent signal was normalized as a percentage of the maximum signal achieved on day 3 (meanϮSEM of 4 experiments). Western blotting of nuclear and cytosolic lysates from SMC transduced with ER␣ and activated for 20 minutes as indicated demonstrated nuclear translocation of ER␣ when activated by 17␤-estradiol (ESTR). C, SMC stably transduced with pLenti or ER␣ were preincubated with 17␤-estradiol (ϩ) or ETOH (-) for 30 minutes, then activated with TGF␤1 for the time indicated. Phosphorylated Smad2 and ␤-actin as a loading control were detected by Western blotting (representative of 2 experiments).
cating that upstream and downstream signaling events likely differed in these cells. Only ER␣ ligands caused nuclear translocation and transcriptional activity at an ERE.
Many studies show that 17␤-estradiol induces apoptosis through ER␣ in SMC. 2, 19 We found that 17␤-estradiol and PPT significantly reduced cell density of native and transduced cells expressing high levels of ER␣, whereas inhibition of ER␣ by siRNA increased cell density.
Our results may explain some differences in coronary events in women and men. ER␣ activation in an affected coronary artery may cause the dedifferentiation and migration of SMC into the intima, causing microvessel dysfunction. Our observation of apoptosis of SMC after estrogen exposure could partly explain why postmenopausal hormone replacement therapy causes higher rates of myocardial infarction through thinning of collagen and rupture of plaques. Figure 6 . ER␣ ligands cause apoptosis of aortic SMC. A, SMC virally transduced with either pLenti or pLenti-ER␣ were exposed for 10 days in EBM-PRF with various stimuli as indicated in Materials and Methods. The cleaved or active form of caspase-3 was detected at 17 and 19 kDa by SDS-PAGE Western blots. B, Representative phase-contrast photographs were taken of SMC containing low ER␣ levels transduced with either pLenti or ER␣ and treated with vehicle (VEH) or 17␤-estradiol (ESTR) for 10 days. C, Representative photographs are shown of cells with high endogenous levels of ER␣ transfected with either control or ER␣ siRNA plasmid and treated with vehicle or 17␤-estradiol for 10 days. D, Phase-contrast photographs were quantitated for pixel density of live (gray) cells in the following groups: pLenti-transduced (Ⅺ) or ER␣transduced (f) cells activated by ER␣ agonists (nϭ5) (i); SMC natively expressing low (Ⅺ) or high (f) ER␣ levels (nϭ4) (ii); or SMC expressing high ER␣ levels transfected with empty (Ⅺ) or siRNA (f) plasmid (nϭ4) (iii).
